Literature DB >> 27099653

Predictors of mortality after transjugular portosystemic shunt.

Mona Ascha1, Sami Abuqayyas1, Ibrahim Hanouneh1, Laith Alkukhun1, Mark Sands1, Raed A Dweik1, Adriano R Tonelli1.   

Abstract

AIM: To investigate if echocardiographic and hemodynamic determinations obtained at the time of transjugular intrahepatic portosystemic shunt (TIPS) can provide prognostic information that will enhance risk stratification of patients.
METHODS: We reviewed medical records of 467 patients who underwent TIPS between July 2003 and December 2011 at our institution. We recorded information regarding patient demographics, underlying liver disease, indication for TIPS, baseline laboratory values, hemodynamic determinations at the time of TIPS, and echocardiographic measurements both before and after TIPS. We recorded patient comorbidities that may affect hemodynamic and echocardiographic determinations. We also calculated Model for End-stage Liver Disease (MELD) score and Child Turcotte Pugh (CTP) class. The following pre- and post-TIPS echocardiographic determinations were recorded: Left ventricular ejection fraction, right ventricular (RV) systolic pressure, subjective RV dilation, and subjective RV function. We recorded the following hemodynamic measurements: Right atrial (RA) pressure before and after TIPS, inferior vena cava pressure before and after TIPS, free hepatic vein pressure, portal vein pressure before and after TIPS, and hepatic venous pressure gradient (HVPG).
RESULTS: We reviewed 418 patients with portal hypertension undergoing TIPS. RA pressure increased by a mean ± SD of 4.8 ± 3.9 mmHg (P < 0.001), HVPG decreased by 6.8 ± 3.5 mmHg (P < 0.001). In multivariate linear regression analysis, a higher MELD score, lower platelet count, splenectomy and a higher portal vein pressure were independent predictors of higher RA pressure (R = 0.55). Three variables predicted 3-mo mortality after TIPS in a multivariate analysis: Age, MELD score, and CTP grade C. Change in the RA pressure after TIPS predicted long-term mortality (per 1 mmHg change, HR = 1.03, 95%CI: 1.01-1.06, P < 0.012).
CONCLUSION: RA pressure increased immediately after TIPS particularly in patients with worse liver function, portal hypertension, emergent TIPS placement and history of splenectomy. The increase in RA pressure after TIPS was associated with increased mortality. Age, splenectomy, MELD score and CTP grade were independent predictors of long-term mortality after TIPS.

Entities:  

Keywords:  Mortality; Outcomes; Right atrial pressure; Transjugular intrahepatic portosystemic shunt; Transjugular portosystemic shunts

Year:  2016        PMID: 27099653      PMCID: PMC4832094          DOI: 10.4254/wjh.v8.i11.520

Source DB:  PubMed          Journal:  World J Hepatol


  36 in total

1.  Mortality and rebleeding following Transjugular Intrahepatic Portosystemic Stent Shunt for variceal haemorrhage.

Authors:  D Williams; R Waugh; N Gallagher; K Perkins; P Dilworth; A Duggan; W Selby
Journal:  J Gastroenterol Hepatol       Date:  1998-02       Impact factor: 4.029

2.  Short-term effects of transjugular intrahepatic shunt on cardiac function assessed by cardiac MRI: preliminary results.

Authors:  A Kovács; M Schepke; J Heller; H H Schild; S Flacke
Journal:  Cardiovasc Intervent Radiol       Date:  2010-04       Impact factor: 2.740

3.  Haemodynamic adaptation two months after transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients.

Authors:  L A Colombato; L Spahr; J P Martinet; M P Dufresne; M Lafortune; D Fenyves; G Pomier-Layrargues
Journal:  Gut       Date:  1996-10       Impact factor: 23.059

4.  Cardiac function and haemodynamics in alcoholic cirrhosis and effects of the transjugular intrahepatic portosystemic stent shunt.

Authors:  M Huonker; Y O Schumacher; A Ochs; S Sorichter; J Keul; M Rössle
Journal:  Gut       Date:  1999-05       Impact factor: 23.059

5.  Diastolic dysfunction is associated with poor survival in patients with cirrhosis with transjugular intrahepatic portosystemic shunt.

Authors:  Massimo Cazzaniga; Francesco Salerno; Giovanni Pagnozzi; Elena Dionigi; Stefania Visentin; Ilaria Cirello; Daniele Meregaglia; Antonio Nicolini
Journal:  Gut       Date:  2006-11-29       Impact factor: 23.059

6.  The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites.

Authors:  A Ochs; M Rössle; K Haag; K H Hauenstein; P Deibert; V Siegerstetter; M Huonker; M Langer; H E Blum
Journal:  N Engl J Med       Date:  1995-05-04       Impact factor: 91.245

7.  Older patient age may predict early mortality after transjugular intrahepatic portosystemic shunt creation in individuals at intermediate risk.

Authors:  Ahmad Parvinian; Kruti D Shah; Patrick M Couture; Jeet Minocha; M Grace Knuttinen; James T Bui; Ron C Gaba
Journal:  J Vasc Interv Radiol       Date:  2013-05-23       Impact factor: 3.464

8.  Left ventricular diastolic function in liver cirrhosis.

Authors:  G Finucci; A Desideri; D Sacerdoti; M Bolognesi; C Merkel; P Angeli; A Gatta
Journal:  Scand J Gastroenterol       Date:  1996-03       Impact factor: 2.423

9.  Cardiovascular complications of cirrhosis.

Authors:  S Møller; J H Henriksen
Journal:  Postgrad Med J       Date:  2009-01       Impact factor: 2.401

10.  Humoral and cardiac effects of TIPS in cirrhotic patients with different "effective" blood volume.

Authors:  Francesco Salerno; Massimo Cazzaniga; Giovanni Pagnozzi; Ilaria Cirello; Antonio Nicolini; Daniele Meregaglia; Larry Burdick
Journal:  Hepatology       Date:  2003-12       Impact factor: 17.425

View more
  8 in total

1.  A Case Report of Portopulmonary Hypertension Precipitated by Transjugular Intrahepatic Portosystemic Shunt.

Authors:  Jasmine H Tatah; E Kenneth Weir; Kurt W Prins; Thenappan Thenappan
Journal:  Chest       Date:  2021-04-06       Impact factor: 9.410

2.  Targeted puncture of left branch of intrahepatic portal vein in transjugular intrahepatic portosystemic shunt to reduce hepatic encephalopathy.

Authors:  Shi-Hua Luo; Jian-Guo Chu; He Huang; Guo-Rui Zhao; Ke-Chun Yao
Journal:  World J Gastroenterol       Date:  2019-03-07       Impact factor: 5.742

Review 3.  Cirrhotic patients and older people.

Authors:  Paul Carrier; Marilyne Debette-Gratien; Jérémie Jacques; Véronique Loustaud-Ratti
Journal:  World J Hepatol       Date:  2019-09-27

4.  Renal-function change after transjugular intra-hepatic portosystemic shunt placement and its relationship with survival: a single-center experience.

Authors:  Min Lang; Angela L Lang; Brian Q Tsui; Weiping Wang; Brian K Erly; Bo Shen; Baljendra Kapoor
Journal:  Gastroenterol Rep (Oxf)       Date:  2020-12-03

Review 5.  The Portosystemic Shunt for the Control of Variceal Bleeding in Cirrhotic Patients: Past and Present.

Authors:  Petre Radu; Virgiliu-Mihail Prunoiu; Victor Strâmbu; Dragos Garofil; Roxana Elena Doncu; Eugen Brătucu; Laurentiu Simion; Maria-Manuela Răvaş; Mircea Nicolae Brătucu
Journal:  Can J Gastroenterol Hepatol       Date:  2022-09-17

6.  Outcomes After TIPS for Ascites and Variceal Bleeding in a Contemporary Era-An ALTA Group Study.

Authors:  Justin Richard Boike; Nikhilesh Ray Mazumder; Kanti Pallav Kolli; Jin Ge; Margarita German; Nathaniel Jest; Giuseppe Morelli; Erin Spengler; Adnan Said; Jennifer C Lai; Archita P Desai; Thomas Couri; Sonali Paul; Catherine Frenette; Elizabeth C Verna; Usman Rahim; Aparna Goel; Dyanna Gregory; Bartley Thornburg; Lisa B VanWagner
Journal:  Am J Gastroenterol       Date:  2021-10-01       Impact factor: 12.045

7.  Effect of initial stent position on patency of transjugular intrahepatic portosystemic shunt.

Authors:  Shi-Hua Luo; Jian-Guo Chu; He Huang; Ke-Chun Yao
Journal:  World J Gastroenterol       Date:  2017-07-14       Impact factor: 5.742

Review 8.  North American Practice-Based Recommendations for Transjugular Intrahepatic Portosystemic Shunts in Portal Hypertension.

Authors:  Justin R Boike; Bartley G Thornburg; Sumeet K Asrani; Michael B Fallon; Brett E Fortune; Manhal J Izzy; Elizabeth C Verna; Juan G Abraldes; Andrew S Allegretti; Jasmohan S Bajaj; Scott W Biggins; Michael D Darcy; Maryjane A Farr; Khashayar Farsad; Guadalupe Garcia-Tsao; Shelley A Hall; Caroline C Jadlowiec; Michael J Krowka; Jeanne Laberge; Edward W Lee; David C Mulligan; Mitra K Nadim; Patrick G Northup; Riad Salem; Joseph J Shatzel; Cathryn J Shaw; Douglas A Simonetto; Jonathan Susman; K Pallav Kolli; Lisa B VanWagner
Journal:  Clin Gastroenterol Hepatol       Date:  2021-07-15       Impact factor: 13.576

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.